98%
921
2 minutes
20
Introduction: Allergic rhinitis (AR) is a prevalent health concern. In Europe, 20-40% of the population is affected. Diagnostic methods include skin tests, measurement of serum immunoglobulin E (IgE), nasal smear for eosinophils, and inhalation provocation tests. The introduction of the nasal allergy test has simplified allergen testing for the direct determination of specific IgE on the nasal mucosa.
Methods: A prospective study conducted from 2010 to 2012 included 102 participants diagnosed with AR and 60 control participants without persistent AR, based on medical history and physical examination. Participants from both groups underwent a nasal test using prepared inhalant allergy panels. Specific IgE was tested using the ELISA processor Hytec 288. The aim of the study was to interpret diagnostic accuracy measures for each allergen panel.
Results: The nasal allergy test demonstrated sensitivity above 75 %, and specificity approaching 90 %. The positive predictive value (PPV) was 91.25 %, while the negative predictive value (NPV) was 71 %. The positive likelihood ratio ranged from 3.75 to 34.59, indicating that a positive result was 10.23 times more likely in patients than in controls. A negative likelihood ratio was 0.25, suggesting that participants in the control group were four times more likely to yield a negative result than allergic individuals.
Conclusion: The nasal allergy test is recommended due to its simplicity, minimal risk profile compared to conventional tests, and high diagnostic reliability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000548221 | DOI Listing |
J Sleep Res
September 2025
Department of Otorhinolaryngology-Head and Neck Surgery, Kansai Medical University, Hirakata, Japan.
In obstructive sleep apnea (OSA), repeated airway obstruction alters mucosal inflammation, which increases exhaled nitric oxide (NO) production in the nasal cavity. However, the underlying mechanism remains unclear. Accordingly, we aimed to examine the mechanism underlying NO production in patients with OSA.
View Article and Find Full Text PDFJ Pain Symptom Manage
September 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland and Department of Palliative Care Centre and Home Hospital Services, Tampere University Hospital, The Wellbeing Services County of Pirkanmaa, Finland.
Context: High-flow nasal therapy (HFNT) may relieve severe dyspnea, but its role compared to other treatment options in palliative care remains unclear.
Objectives: Assess the effect and feasibility of HFNT with air compared to fan therapy in relieving dyspnea among non-hypoxemic patients with incurable cancer.
Methods: This prospective, randomized, controlled, crossover trial compared airflow delivered by HFNT and fan.
J Allergy Clin Immunol Pract
September 2025
Department of Medicine, University of California, Irvine, USA. Electronic address:
Allergy
September 2025
2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.
Nonsteroidal anti-inflammatory drugs (NSAID)-exacerbated respiratory disease (N-ERD) is a mainly type 2 inflammatory condition that combines asthma, nasal polyps, and hypersensitivity to NSAIDs. Its pathogenesis involves both upper and lower airways, yet most studies to date have examined these compartments separately. It remains unclear whether the molecular mechanisms in the nose, sinuses, and lungs are distinct or overlapping-an important gap, given that clinical manifestations of N-ERD involve both sites.
View Article and Find Full Text PDFInt Arch Allergy Immunol
September 2025
Introduction: Allergic rhinitis (AR) is a prevalent health concern. In Europe, 20-40% of the population is affected. Diagnostic methods include skin tests, measurement of serum immunoglobulin E (IgE), nasal smear for eosinophils, and inhalation provocation tests.
View Article and Find Full Text PDF